{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"oculocutaneous-albinism-type-2","columns":[{"gene":"","key":"population-d225b5d3d4ab6d320dbb","label":"Albinism, oculocutaneous, type II","mondoId":"MONDO:0008746","onsetQualifier":null,"originColumnKey":"MONDO:0008746/OMIM:203200","originalViews":[{"key":"MONDO:0008746/OMIM:203200","label":"Albinism, oculocutaneous, type II","scopeLabel":"OMIM:203200","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["06245299b53245ce94f18cac1c1a64b05f647e53ad590de1a0e8aab1e83d4199","0d09ec1d713af598b705ded1dcb66b0faf4b20ae4fac17dca3637fc72a175dbb","1f8ca76a718c283600d1768ab8c842e596cc27cbbfd59cb7531e0769f9bffb5a","248bcf08057757570129df8fa4c4b4e8b9a44034af60a03e33f4cc8d0c38d5a7","357ea1447811c2113380c901a0556ab2862c7c6250d4d3c9d7c22ba760006bfb","3de0059c90c408273cbc2272ae9cafe37c833ee709b2d2c4f32d741a9e661a75","4143a2a7be63730b2554bb3062f95f50e3dbf4ee3c4d5d230491d740b47270d7","50987edc1027edad89b05da32b9c7dec2489c6bb3eb7a5ab972308761b384bf9","59350bc185701fa700e33df8d9e722a41028744dbb16645326ec7448eca993de","5b8d13e1cb6e5bf7ae2425c715937a05574f21dccd167fc15c5d34a42675d2fa","b780240929f044cb403d44afad9dc7bc7ca49bc91d4558d985edaf43e27b5e62","bf34f532e69f81d1204e7aa8e00445d23210eab9a3252b053d1967d4da1e62a2","e1b79e266802d3cecd325af87ca98153559dec829dbec33a165ef96f50c6b73f","f3eda40af380c80bedf6241a724df71c17cb8c56976941cf9eca332074fac78b"],"recordQualifiers":{},"scopeLabel":"OMIM:203200","sourceIds":["OMIM:203200"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-d223766cb6a4dac79761","label":"Oculocutaneous albinism type 2","mondoId":"MONDO:0008746","onsetQualifier":null,"originColumnKey":"MONDO:0008746/ORPHA:79432","originalViews":[{"key":"MONDO:0008746/ORPHA:79432","label":"Oculocutaneous albinism type 2","scopeLabel":"ORPHA:79432","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["02a022ec795ec65ee9de14c96e1645ef1b867f91db1fc80bbb506ea5c66e2459","07d8298bb3765587850fc196be461e81333809fcb8cf0e3292a3d585fe9ad581","0f66492851e0311db5818e534291f4c3efec5569d9b8c400b7a302a3a302bca5","29e5dda703719a45e899d8130340ebec533d9443652e5f798462f16ad6724d51","2a7998b541ad5a6ad53d376dc5bf527b46f068e03e738e607dd8c022576f04c1","3e263ace608081ee337ccbbb166da9e2c07686b84a111dc27e3075beede418fd","6d93105d0c8b53bd2e2ca662e478acfc88f8d0dcec5a10c8abace19fd3af65a5","747f1228304b4a5c383d0f53d841b8e9a93e14adafcc73aa7b3477f5699892a3","7570932bbefcfaf603dc17c6bdb553fe317722808fc3205c5e66312e1f0f099d","7f32b92f35c3e7bab691281fe6b3395ab8eda8713eb1be3f231748b63422c7fd","8fa0ec25f12f198372975a2be1c6b1044860b3fdd9b7ed80bb96f7a47eb2615b","91cec4144fabb9e485658871bbd9a6e883d547fa57b1f99825108e19ca6f8a1d","9678941618bf483ababebcc96bd231b122bd2605db19dddd2175466e2558caf4","98389a7ab4b133c82a85138b1c2edd6735f2ee84a76feb41085ae2c986cc97c5","9a6c2b8c07533695384770e4629b2a0ef685c448dbfb7f3dc59dedd5e786c48c","b8ac8cb15c988be163308f72c440a23b1eaeef493e3e1e4cbeae489c30021a93","be8d0596145b8358b76017f421a5b13af7a635b548da30a4907f601cfb1e4a10","d6305491ba86f835c234823e34c0c433de2c3a40dd129bc4771fdcd598b64f4a","da5314554d15eacaea7b1a0d10b6fe6157726521e03f3ecb78160e8174586bd9","daa13379bb8a194fee51e5935189d054265f9fed520c309e2f2ae13891225dc6","dd570b9adab9623968f8cde8b103018a9586afaef126acd99c65921a7220d4b6","e8cd1385bf4b7878475f4f1bceee07a6c7374229cbbfad8f8dad4404ebc18b11","f5185f98ed464c9138ed06a86e5e13b1659b4e6509bf953fece78dd7921a30bf","fd9e37abf203455627c4f9513ac3bf8e4eaff7b5dda296738115ba9a152548db"],"recordQualifiers":{},"scopeLabel":"ORPHA:79432","sourceIds":["ORPHA:79432"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d225b5d3d4ab6d320dbb","population-d223766cb6a4dac79761"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007703","HP:0000539","HP:0200098","HP:0001022","HP:0002671","HP:0000635","HP:0012056"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":38,"sourceGroups":{"omim":14,"orphanet":24}},"features":[{"hpoId":"HP:0007703","label":"Abnormal retinal pigmentation","primary":true},{"hpoId":"HP:0000539","label":"Abnormality of refraction","primary":true},{"hpoId":"HP:0200098","label":"Absent skin pigmentation","primary":true},{"hpoId":"HP:0001022","label":"Albinism","primary":true},{"hpoId":"HP:0002671","label":"Basal cell carcinoma","primary":true},{"hpoId":"HP:0000635","label":"Blue irides","primary":true},{"hpoId":"HP:0012056","label":"Cutaneous melanoma","primary":true},{"hpoId":"HP:0000577","label":"Exotropia","primary":false},{"hpoId":"HP:0007603","label":"Freckles in sun-exposed areas","primary":false},{"hpoId":"HP:0001480","label":"Freckling","primary":false},{"hpoId":"HP:0007894","label":"Fundus hypopigmentation","primary":false},{"hpoId":"HP:0001100","label":"Heterochromia iridis","primary":false},{"hpoId":"HP:0007481","label":"Hyperpigmented nevi","primary":false},{"hpoId":"HP:0005599","label":"Hypopigmentation of hair","primary":false},{"hpoId":"HP:0001010","label":"Hypopigmentation of the skin","primary":false},{"hpoId":"HP:0007750","label":"Hypoplasia of the fovea","primary":false},{"hpoId":"HP:0007730","label":"Iris hypopigmentation","primary":false},{"hpoId":"HP:0012805","label":"Iris transillumination defect","primary":false},{"hpoId":"HP:0007988","label":"Macular hypopigmentation","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0025551","label":"Optic nerve misrouting","primary":false},{"hpoId":"HP:0000613","label":"Photophobia","primary":false},{"hpoId":"HP:0030856","label":"Posterior staphyloma","primary":false},{"hpoId":"HP:0002297","label":"Red hair","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0006739","label":"Squamous cell carcinoma of the skin","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false},{"hpoId":"HP:0002226","label":"White eyebrow","primary":false},{"hpoId":"HP:0002227","label":"White eyelashes","primary":false},{"hpoId":"HP:0011364","label":"White hair","primary":false}],"ledeHtml":"Oculocutaneous albinism type 2 (OCA2) is a type of OCA and the most common form of OCA seen in the African population, characterized by variable hypopigmentation of the skin and hair, numerous characteristic ocular changes and misrouting of the optic nerves at the chiasm.","mondoId":"MONDO:0008746","node":{"canonicalSlug":"oculocutaneous-albinism-type-2","comparisons":[{"documentSha256":"d972cabe5ad0c2b0cbe4f932912eacf3e7f938d0af4d4a80f5b1830550bb96a2","key":"legacy-oculocutaneous-albinism","kind":"legacy","label":"oculocutaneous albinism","memberIds":["MONDO:0008746","MONDO:0008747","MONDO:0011683","MONDO:0014070","MONDO:0014127","MONDO:0018135","MONDO:0018264","MONDO:0018910","MONDO:0030899"],"mondoId":"MONDO:0018910","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/oculocutaneous-albinism.d972cabe5ad0c2b0cbe4f932912eacf3e7f938d0af4d4a80f5b1830550bb96a2.json"},{"documentSha256":"5896cda54519b93cb09466b74f84c1a44ee288559b6a6a128b0a68d84eac7104","key":"expanded-oculocutaneous-albinism","kind":"expanded","label":"oculocutaneous albinism","memberIds":["MONDO:0008745","MONDO:0008746","MONDO:0008747","MONDO:0011683","MONDO:0011749","MONDO:0014070","MONDO:0014127","MONDO:0018135","MONDO:0018136","MONDO:0018137","MONDO:0018264","MONDO:0018910","MONDO:0030899","MONDO:0040654"],"mondoId":"MONDO:0018910","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-5896cda54519b93cb094.5896cda54519b93cb09466b74f84c1a44ee288559b6a6a128b0a68d84eac7104.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"oculocutaneous albinism type 2","paragraphs":["Oculocutaneous albinism type 2 (OCA2) is a type of OCA and the most common form of OCA seen in the African population, characterized by variable hypopigmentation of the skin and hair, numerous characteristic ocular changes and misrouting of the optic nerves at the chiasm."],"scope":"exact","source":"MONDO","upstream":"Orphanet:79432","url":"https://monarchinitiative.org/MONDO:0008746"},"ownColumnKeys":["population-d225b5d3d4ab6d320dbb","population-d223766cb6a4dac79761"],"publication":"published","relationships":[{"kind":"parent","label":"oculocutaneous albinism","mondoId":"MONDO:0018910","slug":"oculocutaneous-albinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/4038"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"02a022ec795ec65ee9de14c96e1645ef1b867f91db1fc80bbb506ea5c66e2459","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001010","is_excluded":false,"label":"Hypopigmentation of the skin","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"06245299b53245ce94f18cac1c1a64b05f647e53ad590de1a0e8aab1e83d4199","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000577","is_excluded":false,"label":"Exotropia","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"07d8298bb3765587850fc196be461e81333809fcb8cf0e3292a3d585fe9ad581","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011364","is_excluded":false,"label":"White hair","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0d09ec1d713af598b705ded1dcb66b0faf4b20ae4fac17dca3637fc72a175dbb","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001022","is_excluded":false,"label":"Albinism","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"0f66492851e0311db5818e534291f4c3efec5569d9b8c400b7a302a3a302bca5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001100","is_excluded":false,"label":"Heterochromia iridis","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1f8ca76a718c283600d1768ab8c842e596cc27cbbfd59cb7531e0769f9bffb5a","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007603","is_excluded":false,"label":"Freckles in sun-exposed areas","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"248bcf08057757570129df8fa4c4b4e8b9a44034af60a03e33f4cc8d0c38d5a7","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007894","is_excluded":false,"label":"Fundus hypopigmentation","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"29e5dda703719a45e899d8130340ebec533d9443652e5f798462f16ad6724d51","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005599","is_excluded":false,"label":"Hypopigmentation of hair","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2a7998b541ad5a6ad53d376dc5bf527b46f068e03e738e607dd8c022576f04c1","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002226","is_excluded":false,"label":"White eyebrow","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"357ea1447811c2113380c901a0556ab2862c7c6250d4d3c9d7c22ba760006bfb","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3de0059c90c408273cbc2272ae9cafe37c833ee709b2d2c4f32d741a9e661a75","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3e263ace608081ee337ccbbb166da9e2c07686b84a111dc27e3075beede418fd","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012805","is_excluded":false,"label":"Iris transillumination defect","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4143a2a7be63730b2554bb3062f95f50e3dbf4ee3c4d5d230491d740b47270d7","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005599","is_excluded":false,"label":"Hypopigmentation of hair","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"50987edc1027edad89b05da32b9c7dec2489c6bb3eb7a5ab972308761b384bf9","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001010","is_excluded":false,"label":"Hypopigmentation of the skin","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"59350bc185701fa700e33df8d9e722a41028744dbb16645326ec7448eca993de","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5b8d13e1cb6e5bf7ae2425c715937a05574f21dccd167fc15c5d34a42675d2fa","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6d93105d0c8b53bd2e2ca662e478acfc88f8d0dcec5a10c8abace19fd3af65a5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000613","is_excluded":false,"label":"Photophobia","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"747f1228304b4a5c383d0f53d841b8e9a93e14adafcc73aa7b3477f5699892a3","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000635","is_excluded":false,"label":"Blue irides","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7570932bbefcfaf603dc17c6bdb553fe317722808fc3205c5e66312e1f0f099d","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002227","is_excluded":false,"label":"White eyelashes","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7f32b92f35c3e7bab691281fe6b3395ab8eda8713eb1be3f231748b63422c7fd","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007703","is_excluded":false,"label":"Abnormal retinal pigmentation","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8fa0ec25f12f198372975a2be1c6b1044860b3fdd9b7ed80bb96f7a47eb2615b","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0007481","is_excluded":false,"label":"Hyperpigmented nevi","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"91cec4144fabb9e485658871bbd9a6e883d547fa57b1f99825108e19ca6f8a1d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9678941618bf483ababebcc96bd231b122bd2605db19dddd2175466e2558caf4","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001480","is_excluded":false,"label":"Freckling","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98389a7ab4b133c82a85138b1c2edd6735f2ee84a76feb41085ae2c986cc97c5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030856","is_excluded":false,"label":"Posterior staphyloma","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a6c2b8c07533695384770e4629b2a0ef685c448dbfb7f3dc59dedd5e786c48c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000539","is_excluded":false,"label":"Abnormality of refraction","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b780240929f044cb403d44afad9dc7bc7ca49bc91d4558d985edaf43e27b5e62","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b8ac8cb15c988be163308f72c440a23b1eaeef493e3e1e4cbeae489c30021a93","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012056","is_excluded":false,"label":"Cutaneous melanoma","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"be8d0596145b8358b76017f421a5b13af7a635b548da30a4907f601cfb1e4a10","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0200098","is_excluded":false,"label":"Absent skin pigmentation","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"bf34f532e69f81d1204e7aa8e00445d23210eab9a3252b053d1967d4da1e62a2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000635","is_excluded":false,"label":"Blue irides","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d6305491ba86f835c234823e34c0c433de2c3a40dd129bc4771fdcd598b64f4a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da5314554d15eacaea7b1a0d10b6fe6157726521e03f3ecb78160e8174586bd9","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006739","is_excluded":false,"label":"Squamous cell carcinoma of the skin","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"daa13379bb8a194fee51e5935189d054265f9fed520c309e2f2ae13891225dc6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007988","is_excluded":false,"label":"Macular hypopigmentation","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd570b9adab9623968f8cde8b103018a9586afaef126acd99c65921a7220d4b6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025551","is_excluded":false,"label":"Optic nerve misrouting","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e1b79e266802d3cecd325af87ca98153559dec829dbec33a165ef96f50c6b73f","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e8cd1385bf4b7878475f4f1bceee07a6c7374229cbbfad8f8dad4404ebc18b11","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007730","is_excluded":false,"label":"Iris hypopigmentation","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f3eda40af380c80bedf6241a724df71c17cb8c56976941cf9eca332074fac78b","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:203200","disease_name":"Albinism, oculocutaneous, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002297","is_excluded":false,"label":"Red hair","onset_id":null,"reference":"OMIM:203200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f5185f98ed464c9138ed06a86e5e13b1659b4e6509bf953fece78dd7921a30bf","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002671","is_excluded":false,"label":"Basal cell carcinoma","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fd9e37abf203455627c4f9513ac3bf8e4eaff7b5dda296738115ba9a152548db","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79432","disease_name":"Oculocutaneous albinism type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"ORPHA:79432","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008746\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:79432</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Oculocutaneous albinism type 2 (OCA2) is a type of OCA and the most common form of OCA seen in the African population, characterized by variable hypopigmentation of the skin and hair, numerous characteristic ocular changes and misrouting of the optic nerves at the chiasm.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008746\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"oculocutaneous-albinism-type-2","sourceDocuments":[{"name":"MONDO: oculocutaneous albinism type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0008746"}],"sourceNote":"","synonyms":["albinism, oculocutaneous, type 2","albinism, oculocutaneous, type II","albinism, oculocutaneous, type II, modifier of","Albinoidism","OCA2","oculocutaneous albinism type 2","oculocutaneous albinism tyrosinase positive","oculocutaneous albinism, tyrosinase-positive","tyrosinase-positive oculocutaneous albinism"],"takeawayHtml":"","title":"oculocutaneous albinism type 2"},"schemaVersion":1}
